Clinical Trial

Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics

Study acronym: ECMANDO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 19, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study explores the immune landscape of chronic hand eczema using spatial transcriptomics and single-cell proteomics, offering new insights into disease mechanisms and potential therapeutic targets.
Trial Details
NCT Number NCT06884163
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborators: LEO Pharma
Conditions Hand Eczema
Enrollment 40 participants
Start Date 2025-01-13
Primary Completion 2026-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-19